BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 16150947)

  • 1. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.
    Bryceson YT; March ME; Ljunggren HG; Long EO
    Blood; 2006 Jan; 107(1):159-66. PubMed ID: 16150947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
    Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
    Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2B4 functions as a co-receptor in human NK cell activation.
    Sivori S; Parolini S; Falco M; Marcenaro E; Biassoni R; Bottino C; Moretta L; Moretta A
    Eur J Immunol; 2000 Mar; 30(3):787-93. PubMed ID: 10741393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways.
    Chuang SS; Kumaresan PR; Mathew PA
    J Immunol; 2001 Dec; 167(11):6210-6. PubMed ID: 11714782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.
    Bryceson YT; Ljunggren HG; Long EO
    Blood; 2009 Sep; 114(13):2657-66. PubMed ID: 19628705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.
    Marcenaro E; Augugliaro R; Falco M; Castriconi R; Parolini S; Sivori S; Romeo E; Millo R; Moretta L; Bottino C; Moretta A
    Eur J Immunol; 2003 Dec; 33(12):3367-76. PubMed ID: 14635045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.
    Mooney JM; Klem J; Wülfing C; Mijares LA; Schwartzberg PL; Bennett M; Schatzle JD
    J Immunol; 2004 Sep; 173(6):3953-61. PubMed ID: 15356144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244).
    Watzl C; Stebbins CC; Long EO
    J Immunol; 2000 Oct; 165(7):3545-8. PubMed ID: 11034353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset.
    Barakonyi A; Rabot M; Marie-Cardine A; Aguerre-Girr M; Polgar B; Schiavon V; Bensussan A; Le Bouteiller P
    J Immunol; 2004 Nov; 173(9):5349-54. PubMed ID: 15494480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.
    Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ
    Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells.
    Stark S; Watzl C
    Int Immunol; 2006 Feb; 18(2):241-7. PubMed ID: 16410313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza.
    Jost S; Reardon J; Peterson E; Poole D; Bosch R; Alter G; Altfeld M
    Immunology; 2011 Apr; 132(4):516-26. PubMed ID: 21214542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.
    Lee KM; Forman JP; McNerney ME; Stepp S; Kuppireddi S; Guzior D; Latchman YE; Sayegh MH; Yagita H; Park CK; Oh SB; Wülfing C; Schatzle J; Mathew PA; Sharpe AH; Kumar V
    Blood; 2006 Apr; 107(8):3181-8. PubMed ID: 15905190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.
    Kim EO; Kim TJ; Kim N; Kim ST; Kumar V; Lee KM
    J Biol Chem; 2010 Dec; 285(53):41755-64. PubMed ID: 20813844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
    Messmer B; Eissmann P; Stark S; Watzl C
    J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C is involved in 2B4 (CD244)-mediated cytotoxicity and AP-1 activation in natural killer cells.
    Chuang SS; Lee JK; Mathew PA
    Immunology; 2003 Jul; 109(3):432-9. PubMed ID: 12807490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.